DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,596,037 | +1.6% | 50,770 | -1.7% | 0.17% | +18.4% |
| Q2 2023 | $12,401,760 | -2.9% | 51,674 | +2.0% | 0.15% | -7.0% |
| Q1 2023 | $12,767,086 | -4.6% | 50,655 | +0.5% | 0.16% | -8.7% |
| Q4 2022 | $13,379,557 | +3.6% | 50,409 | +0.8% | 0.17% | -6.0% |
| Q3 2022 | $12,914,000 | +1.7% | 49,999 | -0.2% | 0.18% | -4.2% |
| Q2 2022 | $12,695,000 | -15.2% | 50,075 | -1.9% | 0.19% | +25.5% |
| Q1 2022 | $14,972,000 | -11.8% | 51,043 | -1.1% | 0.15% | -18.2% |
| Q4 2021 | $16,983,000 | +4.9% | 51,617 | -2.9% | 0.19% | +1.1% |
| Q3 2021 | $16,191,000 | +14.0% | 53,184 | +0.5% | 0.18% | +16.4% |
| Q2 2021 | $14,198,000 | -65.4% | 52,907 | -71.0% | 0.16% | -67.4% |
| Q1 2021 | $41,015,000 | +3.4% | 182,224 | +2.1% | 0.49% | -6.3% |
| Q4 2020 | $39,666,000 | +30.8% | 178,561 | +26.8% | 0.52% | +16.3% |
| Q3 2020 | $30,330,000 | +17.7% | 140,853 | -3.4% | 0.45% | +17.3% |
| Q2 2020 | $25,774,000 | +34.9% | 145,753 | +5.6% | 0.38% | +15.8% |
| Q1 2020 | $19,112,000 | -26.3% | 138,081 | -18.3% | 0.33% | -9.1% |
| Q4 2019 | $25,946,000 | -7.6% | 169,051 | -13.1% | 0.36% | -2.2% |
| Q3 2019 | $28,088,000 | +0.1% | 194,472 | -1.0% | 0.37% | -3.1% |
| Q2 2019 | $28,065,000 | +234.7% | 196,370 | +209.2% | 0.38% | +221.0% |
| Q1 2019 | $8,384,000 | +22.2% | 63,503 | -4.6% | 0.12% | +10.2% |
| Q4 2018 | $6,863,000 | -6.3% | 66,554 | -1.2% | 0.11% | +6.9% |
| Q3 2018 | $7,322,000 | +10.1% | 67,382 | 0.0% | 0.10% | +3.1% |
| Q2 2018 | $6,649,000 | +3.0% | 67,382 | +2.2% | 0.10% | 0.0% |
| Q1 2018 | $6,458,000 | -44.3% | 65,957 | -49.1% | 0.10% | +8.9% |
| Q4 2017 | $11,585,000 | +111.6% | 129,656 | +103.1% | 0.09% | +2.3% |
| Q3 2017 | $5,475,000 | +2.2% | 63,828 | +0.6% | 0.09% | -3.3% |
| Q2 2017 | $5,357,000 | -56.7% | 63,478 | -56.1% | 0.09% | -62.2% |
| Q1 2017 | $12,359,000 | +9.8% | 144,496 | -0.1% | 0.24% | +3.4% |
| Q4 2016 | $11,255,000 | +3.1% | 144,596 | +3.8% | 0.23% | -1.3% |
| Q3 2016 | $10,917,000 | -7.1% | 139,271 | +19.7% | 0.24% | -10.3% |
| Q2 2016 | $11,756,000 | +1.1% | 116,392 | -5.1% | 0.26% | -1.5% |
| Q1 2016 | $11,629,000 | +3.0% | 122,592 | +0.8% | 0.27% | +0.8% |
| Q4 2015 | $11,291,000 | +54.0% | 121,561 | +41.2% | 0.26% | +44.8% |
| Q3 2015 | $7,333,000 | -0.4% | 86,061 | +0.1% | 0.18% | +7.0% |
| Q2 2015 | $7,359,000 | +4.0% | 85,980 | +3.1% | 0.17% | +4.3% |
| Q1 2015 | $7,079,000 | +0.1% | 83,380 | +1.1% | 0.16% | -1.2% |
| Q4 2014 | $7,069,000 | +15.2% | 82,480 | +2.2% | 0.17% | +9.2% |
| Q3 2014 | $6,134,000 | -2.4% | 80,731 | +1.1% | 0.15% | -2.6% |
| Q2 2014 | $6,285,000 | +12.7% | 79,831 | +7.4% | 0.16% | +6.8% |
| Q1 2014 | $5,575,000 | -2.7% | 74,331 | +0.1% | 0.15% | -4.6% |
| Q4 2013 | $5,731,000 | +27.7% | 74,231 | +14.7% | 0.15% | -15.9% |
| Q3 2013 | $4,487,000 | +11.0% | 64,731 | +1.3% | 0.18% | +5.2% |
| Q2 2013 | $4,044,000 | – | 63,883 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |